In vitro cell-based assays for drug and chemical discovery and development
Newcells Biotech has raised €4.2M across 2 funding rounds from 5 investors, most recently a round in Dec 2024. Based in Newcastle, UK; active in Healthtech. Data as of 7 Aug 2026.
Timing: in window vs cohort gap · momentum down. Funding-only estimates, not predictions and not investment advice — see signals.
| Date |
|---|
| Stage |
|---|
| Amount |
|---|
| Investors |
|---|
| 2024-12-05 | Other | €1.4M | Mercia Ventures,North East Finance,Northstar Ventures | View deal → |
| 2024-02-14 | Other | €2.8M | European regional development fund (ERDF),Mercia Ventures,North East Venture Fund,Northstar Ventures | View deal → |
